| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/04/2003 | US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation. |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166521 Inhibition of thrombosis by treatment with P-selectin antagonists |
| 09/04/2003 | US20030166285 Methods and compositions for genetically modifying primate bone marrow cells |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166229 Human POSH-like protein 1 |
| 09/04/2003 | US20030166224 18232, a novel dual specificity phosphatase and uses therefor |
| 09/04/2003 | US20030166194 Of given sequence; genetic mapping; anticoagulants |
| 09/04/2003 | US20030166044 Novel proteins |
| 09/04/2003 | US20030165896 Inhibitors of human plasmin derived from the kunitz domains |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
| 09/04/2003 | US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents |
| 09/04/2003 | CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/04/2003 | CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | CA2475963A1 Methods of treating vascular disease |
| 09/03/2003 | EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/03/2003 | EP1340753A1 Carbamate derivatives, process for producing the same and use thereof |
| 09/03/2003 | EP1339753A2 Percarboxylated polysaccharides, and a process for their preparation |
| 09/03/2003 | EP1339749A1 Dextran-hemoglobin conjugates as blood substitutes |
| 09/03/2003 | EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/03/2003 | EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339715A2 Heterocyclic ether substituted imidazoquinolines |
| 09/03/2003 | EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 09/03/2003 | EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 09/03/2003 | EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 09/03/2003 | EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 09/03/2003 | EP1339691A1 Novel compounds |
| 09/03/2003 | EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 09/03/2003 | EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | EP1339663A2 Naphthalene derivatives |
| 09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 09/03/2003 | EP1339385A1 Skin cream stimulating the surface bloodstream |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | EP0977741B1 Substituted phenyl derivatives, their preparation and use |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
| 09/03/2003 | CN1440388A Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1440387A Alpha crystalline form of perindopril tert-butyllamine salt |
| 09/03/2003 | CN1440386A Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440283A Combination of organic compounds |
| 09/03/2003 | CN1440277A Particular carrier with active components with improved oral absorbing performance |
| 09/03/2003 | CN1439629A Laevo potassium aspartate material and preparation therefrom and preparing method thereof |
| 09/03/2003 | CN1439628A Ferulaic acid esters and preparation and application thereof |
| 09/03/2003 | CN1439426A Medicine composition and preparation and use thereof |
| 09/03/2003 | CN1439379A Use of salivary gland secreta of cyclostomata in preparing medicines |
| 09/03/2003 | CN1439374A Solid oral preparation of sodium copper chlorophyllin and its preparing method |
| 09/03/2003 | CN1439365A Diacetyl amide acetate ethylenediamide freeze dried powder injection, large volume injection and their preparing method |
| 09/02/2003 | US6614831 Mounting arrangement for auxiliary burner or lance |
| 09/02/2003 | US6613916 Process for the preparation of amorphous atorvastatin |
| 09/02/2003 | US6613897 Of given formula; prepared by depolymerizing hyaluronan with an enzyme derived from Streptomyces; use for treatment of thrombosis and cardiovascular diseases; use in molded products, artificial organs, medical devices, coating agents |
| 09/02/2003 | US6613890 Analogues of Kunitz protease inhibitor domain of amyloid precursor protein bind to and inhibit activity of serine proteases including kallikrein, plasmin, and coagulation factors VIIa, IXa, Xa, XIa, and XIIa; for treating blood loss |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613784 Cyclooxygenase inhibitors such as 2-acetyloxybenzoic acid 6-(nitroxymethyl)-2-methylpyridinyl ester hydrochloride, having good kinetics, solubility and efficiency; nontoxic |
| 09/02/2003 | US6613739 Immunosuppressants |
| 09/02/2003 | US6613573 Blood coagulation analyzer for determining the efficacy of anti-coagulant therapy by measuring blood clot strength; use in treatment of clotting disorders and in surgical and medical procedures |
| 09/02/2003 | US6613566 Platelet suspensions and methods for resuspending platelets |
| 09/02/2003 | US6613328 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies |
| 08/28/2003 | WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070751A2 Partial peptide mimetics and methods |
| 08/28/2003 | WO2003070746A2 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
| 08/28/2003 | WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer |
| 08/28/2003 | WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/28/2003 | WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 08/28/2003 | WO2003070275A1 Use of an inhibitor or antagonist against tissue factor |
| 08/28/2003 | WO2003070249A1 Combination consisting of trapidil and serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
| 08/28/2003 | WO2003070235A1 Medicinal compositions for inhibiting tryptase |
| 08/28/2003 | WO2003070184A2 Sodium channel blockers |
| 08/28/2003 | WO2003070182A2 Sodium channel blockers |
| 08/28/2003 | WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 08/28/2003 | WO2003031447A3 Pyrimidine derivatives |
| 08/28/2003 | WO2003028756A3 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 08/28/2003 | WO2003016335A3 Irreversible cysteine protease inhibitors of legumain |
| 08/28/2003 | WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace |
| 08/28/2003 | WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 08/28/2003 | WO2002094192A3 Antibodies against tumor necrosis factor delta (april) |
| 08/28/2003 | WO2002068469A3 Modified thrombopoietin with reduced immunogenicity |
| 08/28/2003 | WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha |
| 08/28/2003 | WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 08/28/2003 | US20030163845 Elongase genes and uses thereof |
| 08/28/2003 | US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa |
| 08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 08/28/2003 | US20030162826 Degradation fragments |
| 08/28/2003 | US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis |
| 08/28/2003 | US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain |
| 08/28/2003 | US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 08/28/2003 | US20030162799 Squaric acid derivatives |
| 08/28/2003 | US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/28/2003 | US20030162784 Pyridazinone aldose reductase inhibitors |
| 08/28/2003 | US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 08/28/2003 | US20030162775 Heterocyclic substituted pyrazolones |
| 08/28/2003 | US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis |
| 08/28/2003 | US20030162765 Use in treatment and prevention of central nervous system and other disorders |
| 08/28/2003 | US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein |